Source: http://oncchpl.force.com/ehrcert/productdetails?productNumber=66040
Timestamp: 2016-06-01 07:16:02
Document Index: 745708961

Matched Legal Cases: ['§ 170', '§ 170', '§ 170', '§ 170', '§ 170', '§ 170', '§ 170', '§ 170']

iPatientCare Inpatient EHR
2014 (2.0)
Last Modified 07/17/2014
140180R00
iPatientCare EIA (Enterprise Integration Adaptors), iPatientCare HISP, MedlinePlus Connect, Meinberg NTP Time Server Monitor, iPatientCare PHR
Certification Criteria (44)
Clinical Quality Measures (16)
170.314(a)(2)
170.314(a)(3)
170.314(a)(4)
Vital signs, body mass index, and growth charts. (i) Vital signs. Enable a user to electronically record, change, and access, at a minimum, a patientâ€™s height/length, weight, and blood pressure. Height/length, weight, and blood pressure must be recorded in numerical values only. (ii) Calculate body mass index. Automatically calculate and electronically display body mass index based on a patientâ€™s height and weight. (iii) Optionalâ€”Plot and display growth charts. Plot and electronically display, upon request, growth charts for patients.
170.314(a)(5)
170.314(a)(6)
170.314(a)(7)
170.314(a)(10)
170.314(a)(13)
170.314(a)(16)
Electronic medication administration record. (i) In combination with an assistive technology that provides automated information on the â€œrightsâ€? specified in paragraphs (a)(16)(i)(A) through (E) of this section, enable a user to electronically verify the following before administering medication(s): (A) Right patient. The patient to whom the medication is to be administered matches the medication to be administered. (B) Right medication. The medication to be administered matches the medication ordered for the patient. (C) Right dose. The dose of the medication to be administered matches the dose of the medication ordered for the patient. (D) Right route. The route of medication delivery matches the route specified in the medication order. (E) Right time. The time that the medication was ordered to be administered compared to the current time. (ii) Right documentation. Electronically record the time and date in accordance with the standard specified in Â§ 170.210(g), and user identification when a medication is administered.
170.314(a)(17)
Advance directives. Enable a user to electronically record whether a patient has an advance directive.
170.314(a)(18)
COMPUTERIZED PROVIDER ORDER ENTRY - MEDICATIONS
170.314(a)(19)
COMPUTERIZED PROVIDER ORDER ENTRY - LABORATORY
170.314(a)(20)
COMPUTERIZED PROVIDER ORDER ENTRY - DIAGNOSTIC IMAGING
170.314(b)(1)
TRANSITIONS OF CARE - RECEIVE, DISPLAY, AND INCORPORATE TRANSITION OF CARE/REFERRAL SUMMARIES
TRANSITIONS OF CARE - CREATE AND TRANSMIT TRANSITION OF CARE/REFERRAL SUMMARIES
170.314(b)(4)
170.314(b)(6)
TRANSMISSION OF ELECTRONIC LABORATORY TESTS AND VALUES/RESULTS TO AMBULATORY PROVIDERS
Transmission of electronic laboratory tests and values/results to ambulatory providers. EHR technology must be able to electronically create laboratory test reports for electronic transmission in accordance with the standard specified in Â§ 170.205(j) and with laboratory tests expressed in accordance with, at a minimum, the version of the standard specified in Â§ 170.207(c)(2).
170.314(b)(8)
170.314(b)(9)
170.314(c)(1)
CLINICAL QUALITY MEASURES - CAPTURE AND EXPORT
170.314(c)(2)
170.314(c)(3)
CLINICAL QUALITY MEASURES - ELECTRONIC SUBMISSION
170.314(d)(1)
170.314(d)(2)
170.314(d)(3)
170.314(d)(4)
170.314(d)(9)
ACCOUNTING OF DISCLOSURES (OPTIONAL)
Accounting of disclosures. Record disclosures made for treatment, payment, and health care operations in accordance with the standard specified in Â§ 170.210(d).
170.314(e)(1)
170.314(e)(3)
170.314(f)(1)
170.314(f)(2)
170.314(f)(3)
TRANSMISSION TO PUBLIC HEALTH AGENCIES - SYNDROMIC SURVEILLANCE
170.314(f)(4)
Transmission of reportable laboratory tests and values/results. HER technology must be able to electronically create reportable laboratory tests and values/results for electronic transmission in accordance with: (i) The standard (and applicable implementation specifications) specified in Â§ 170.205(g); and (ii) At a minimum, the versions of the standards specified in Â§ 170.207(a)(3) and (c)(2).
170.314(f)(5)
CANCER CASE INFORMATION
Cancer case information. Enable a user to electronically record, change, and access cancer case information.
170.314(f)(6)
Transmission to cancer registries. EHR technology must be able to electronically create cancer case information for electronic transmission in accordance with: (i) The standard (and applicable implementation specifications) specified in Â§ 170.205(i); and (ii) At a minimum, the versions of the standards specified in Â§ 170.207(a)(3) and (c)(2).
170.314(f)(7)
170.314(g)(1)
Automated numerator recording. For each meaningful use objective with a percentage-based measure, EHR technology must be able to create a report or file that enables a user to review the patients or actions that would make the patient or action eligible to be included in the measureâ€™s numerator. The information in the report or file created must be of sufficient detail such that it enables a user to match those patients or actions to meet the measure's denominator limitations when necessary to generate an accurate percentage.
170.314(h)(1)
170.314(h)(2)
APPLICABILITY STATEMENT FOR SECURE HEALTH TRANSPORT AND XDR/XDM FOR DIRECT MESSAGING
170.314(h)(3)
SOAP TRANSPORT AND SECURITY SPECIFICATION AND XDR/XDM FOR DIRECT MESSAGING
View Certified CQMs
View All CQMs
Exclusive breast milk feeding during the newborn's entire hospitalization.
Acute Myocardial Infarction (AMI) patients who are prescribed a statin at hospital discharge.
EHDI-1A - HEARING SCREENING PRIOR TO HOSPITAL DISCHARGE
ED-3-MEDIAN TIME FROM ED ARRIVAL TO ED DEPARTURE FOR DISCHARGED ED PATIENTS.
Median time from emergency department arrival to time of departure from the emergency room for patients discharged from the emergency department.
AMI-8A- PRIMARY PCI RECEIVED WITHIN 90 MINUTES OF HOSPITAL ARRIVAL
Median time from emergency department arrival to time of departure from the emergency room for patients admitted to the facility from the emergency department.
Percentage of patients aged 18 years and older with primary total hip arthroplasty (THA) who completed baseline and follow-up (patient-reported) functional status assessments.
AMI-7A- FIBRINOLYTIC THERAPY RECEIVED WITHIN 30 MINUTES OF HOSPITAL ARRIVAL
Percentage of patients, regardless of age, with a diagnosis of HIV/AIDS with at least two medical visits during the measurement year with a minimum of 60 days between each visit
PREVENTIVE CARE AND SCREENING: RISK- STRATIFIED CHOLESTEROL – FASTING LOW DENSITY LIPOPROTEIN (LDL-C)
Percentage of patients aged 18 years and older with a calculated BMI in the past six months or during the current reporting period documented in the medical record AND if the most recent BMI is outside of normal parameters, a follow-up plan is documented within the past six months or during the current reporting period.
Age 18-64 years BMI - 18.5 and < 25
Ischemic stroke patients administered antithrombotic therapy by the end of hospital day two.
VTE-3 VTE PATIENTS WITH ANTICOAGULATION OVERLAPTHERAPY
This measure assesses the number of patients diagnosed with confirmed VTE who received an overlap of parenteral (intravenous [IV] or subcutaneous [subcu]) anticoagulation and warfarin therapy. For patients who received less than five days of overlap therapy, they must be discharged on both medications or have a reason for discontinuation of overlap therapy. Overlap therapy must be administered for at least five days with an international normalized ratio (INR) greater than or equal to 2 prior to discontinuation of the parenteral anticoagulation therapy, discharged on both medications or have a reason for discontinuation of overlap therapy.
Acute ischemic stroke patients who arrive at this hospital within 2 hours (120 minutes) of time last known well and for whom IV t-PA was initiated at this hospital within 3 hours (180 minutes) of time last known well.
Acute myocardial infarction (AMI) patients who are prescribed aspirin at hospital discharge.
Ischemic stroke patients with LDL greater than or equal to 100 mg/dL, or LDL not measured, or, who were on a lipid-lowering medication prior to hospital arrival are prescribed statin medication at hospital discharge.
This measure assesses the number of patients diagnosed with confirmed VTE that are discharged to home, home care, court/law enforcement, or home on hospice care on warfarin with written discharge instructions that address all four criteria: compliance issues, dietary advice, follow-up monitoring, and information about the potential for adverse drug reactions/interactions.
Patients with elective vaginal deliveries or elective cesarean sections at >= 37 and < 39 weeks of gestation completed.
This measure assesses the number of patients diagnosed with confirmed VTE during hospitalization (not present at admission) who did not receive VTE prophylaxis between hospital admission and the day before the VTE diagnostic testing order date.
CMS128
Percentage of patients aged 18 years and older with a diagnosis of uncomplicated cataract who had cataract surgery and had any of a specified list of surgical procedures in the 30 days following cataract surgery which would indicate the occurrence of any of the following major complications: retained nuclear fragments, endophthalmitis, dislocated or wrong power IOL, retinal detachment, or wound dehiscence.
Percentage of patients aged 18 years and older with a diagnosis of uncomplicated cataract who had cataract surgery and no significant ocular conditions impacting the visual outcome of surgery and had best-corrected visual acuity of 20/40 or better (distance or near) achieved within 90 days following the cataract surgery.
Percentage of children 6-12 years of age and newly dispensed a medication for attention-deficit/hyperactivity disorder (ADHD) who had appropriate follow-up care. Two rates are reported. a. Percentage of children who had one follow-up visit with a practitioner with prescribing authority during the 30-Day Initiation Phase.
Percentage of patients aged 18 through 80 years with Stage III colon cancer who are referred for adjuvant chemotherapy, prescribed adjuvant chemotherapy, or have previously received adjuvant chemotherapy within the 12-month reporting period
Percentage of patients aged 18 years and older with a diagnosis of POAG who have an optic nerve head evaluation during one or more office visits within 12 months
CMS145
CORONARY ARTERY DISEASE (CAD): BETA-BLOCKER THERAPY- PRIOR MYOCARDIAL INFARCTION (MI) OR LEFT VENTRICULAR SYSTOLIC DYSFUNCTION (LVEF <40%)
CMS147
CMS148
CMS154
2. Percentage of patients with counseling for nutrition 3. Percentage of patients with counseling for physical activity
a.Â Â Â Percentage of patients who were ordered at least one high-risk medication. b.Â Â Â Percentage of patients who were ordered at least two different high-risk medications.
CMS158
Surgical patients with prophylactic antibiotics initiated within one hour prior to surgical incision. Patients who received Vancomycin or a Fluoroquinolone for prophylactic antibiotics should have the antibiotics initiated within 2 hours prior to surgical incision. Due to the longer infusion time required for Vancomycin or a Fluoroquinolone, it is acceptable to start these antibiotics within 2 hours prior to incision time.
SCIP-INF-2-PROPHYLACTIC ANTIBIOTIC SELECTION FOR SURGICAL PATIENTS
SCIP-INF-9- URINARY CATHETER REMOVED ON POSTOPERATIVE DAY 1 (POD1) OR POSTOPERATIVE DAY 2 (POD2) WITH DAY OF SURGERY BEING DAY ZERO.
ADE PREVENTION AND MONITORING: WARFARIN TIME IN THERAPEUTIC RANGE.
Percent of term singleton livebirths (excluding those with diagnoses originating in the fetal period) who DO NOT have significant complications during birth or the nursery care.
PN-6- INITIAL ANTIBIOTIC SELECTION FOR COMMUNITY-ACQUIRED PNEUMONIA (CAP) IN IMMUNOCOMPETENT PATIENTS
Immunocompetent patients with Community-Acquired Pneumonia who receive an initial antibiotic regimen during the first 24 hours that is consistent with current guidelines.
CMS190
ONC Certification Website |
Certification Program Regulatory Guidance |
CMS EHR Certification ID Product Lookup |